KLK5 and breast cancer: Downregulation of KLK5 expression levels was observed in breast cancer specimens compared with benign specimens and exhibited a significant and independent value for the discrimination of malignant from benign mammary gland biopsies in logistic regression and receiver‐operating curve analysis [31].